Literature DB >> 8133985

Hemodynamic parameters in patients with acute cervical cord trauma: description, intervention, and prediction of outcome.

L Levi1, A Wolf, H Belzberg.   

Abstract

The cardiovascular response of the patient with acute spinal cord injury (SCI) is known to be altered secondary to the cord injury. Our current protocol of managing the acute phase of patients with SCI includes invasive hemodynamic monitoring (with arterial line and Swan-Ganz catheter) and support with fluids and dopamine and/or dobutamine, titrated to maintain a hemodynamic profile with adequate cardiac output (to be determined by oxygen consumption and delivery) and a mean blood pressure of > 90 mm Hg. We feel that this protocol provides two benefits: 1) maintaining the mean blood pressure improves the morbidity of these patients by deterring ischemia and accompanying secondary insults; 2) aggressive monitoring and hemodynamic intervention help stabilize the hemodynamic status of these patients and make it possible to consider early surgery in selected cases. Our hypothesis is that the pulmonary vascular bed is more sensitive to the sympathectomized effect of acute complete cervical SCI. We analyzed the demographic, neurologic, and hemodynamic data of 50 consecutive patients during their first week postinjury. All had signs of myelopathy; 31 (62%) were considered clinically complete. Of the 50 patients, 9 (18%) died, 20 did not improve functionally, and 21 improved. The mean heart rate (82.1 +/- 13.3), blood pressure (94.4 +/- 9.4), pulmonary artery pressure (22 +/- 5) and wedge (12.7 +/- 3.4), cardiac index (4.5 +/- 0.9), systemic vascular resistance index (SVRI) (1637 +/- 399), pulmonary vascular resistance index (PVRI) (181 +/- 80), and oxygen transport (694 +/- 156) showed good response to the treatment. Because the measurements were obtained during treatment, they differ from the expected "classic sympathectomized" response, but they provide a database for further analysis of hemodynamic manipulation in SCI. An analysis of the hemodynamic parameters did not differentiate between complete and incomplete lesions or between patients with functional improvement. We determined, on the basis of the initial hemodynamic measurements, that no patient with a clinically complete motor deficit (Frankel Grade A+B) improved of the 10 who had measurements compatible with either: 1) PVRI < 100 with SVRI < 1200; or 2) PVRI < 115 with SVRI < 1300 or PVR/SVR ratio of < 0.08 when SVRI was < 1600. These patients could not have other measurements that showed low SVRI < 1350 with PVRI > 139. At odds with this unique group, 13 of 29 patients with the same clinical picture and without the above physiological criteria of severe hemodynamic deficit eventually improved (P < 0.05).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8133985

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  40 in total

1.  Acute changes in systemic hemodynamics and serum vasopressin after complete cervical spinal cord injury in piglets.

Authors:  Michael Zahra; Amer Samdani; Kurt Piggott; Manuel Gonzalez-Brito; Juan Solano; Roosevelt De Los Santo; Juan C Buitrago; Farid Alam; Dansha He; John P Gaughan; Randal Betz; Dalton Dietrich; John Kuluz
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

2.  Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study.

Authors:  A Dakson; D Brandman; G Thibault-Halman; S D Christie
Journal:  Spinal Cord       Date:  2017-06-20       Impact factor: 2.772

3.  Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data.

Authors:  Gregory Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  J Neurotrauma       Date:  2015-08-17       Impact factor: 5.269

4.  Hemodynamic parameters and timing of surgical decompression in acute cervical spinal cord injury.

Authors:  Sagun Tuli; Jayshree Tuli; William P Coleman; Fred H Geisler; Andrei Krassioukov
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals.

Authors: 
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 6.  Modern Medical Management of Spinal Cord Injury.

Authors:  Michael Karsy; Gregory Hawryluk
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-30       Impact factor: 5.081

7.  The differential effects of norepinephrine and dopamine on cerebrospinal fluid pressure and spinal cord perfusion pressure after acute human spinal cord injury.

Authors:  F Altaf; D E Griesdale; L Belanger; L Ritchie; J Markez; T Ailon; M C Boyd; S Paquette; C G Fisher; J Street; M F Dvorak; B K Kwon
Journal:  Spinal Cord       Date:  2016-06-07       Impact factor: 2.772

8.  Severity of locomotor and cardiovascular derangements after experimental high-thoracic spinal cord injury is anesthesia dependent in rats.

Authors:  Yvette S Nout; Michael S Beattie; Jacqueline C Bresnahan
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

9.  The effect of preexisting hypertension on early neurologic results of patients with an acute spinal cord injury.

Authors:  C K Kepler; G D Schroeder; N D Martin; A R Vaccaro; M Cohen; M S Weinstein
Journal:  Spinal Cord       Date:  2015-04-28       Impact factor: 2.772

10.  Higher Mean Arterial Pressure Values Correlate with Neurologic Improvement in Patients with Initially Complete Spinal Cord Injuries.

Authors:  Joshua Stephen Catapano; Gregory William John Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  World Neurosurg       Date:  2016-08-23       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.